Lonza
Anita Keane is an accomplished Executive Director and Global Head of Digital Marketing at Lonza since October 2017, where responsibilities include defining and executing a transformative digital marketing strategy across CDMO divisions to enhance customer acquisition, development, and retention. With a strong background in digital strategy development, Anita previously held roles at EY as Global Strategy and Planning Leader, enhancing brand and marketing communications, and at Thomson Reuters as Global Product Strategy Lead, where strategic growth initiatives were implemented for life science solutions. Prior experience also includes senior positions at GE Healthcare, focusing on global strategy and business development, and various roles at Agilent Technologies, achieving notable sales milestones. Anita holds a PhD in Protein Biochemistry from the University of Birmingham, an MCIM from The Chartered Institute of Marketing, and a BSc in Biochemistry from University College Cork.
This person is not in any teams
This person is not in any offices
Lonza
66 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.